Adocia, Lilly partner on ultra-rapid insulin formulation; deal terminated, then revived, only to be terminated again
- Controlled Release
- Drug Delivery
- Large Molecule
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.